ONCOLOGY, NUCLEAR MEDICINE AND TRANSPLANTOLOGY

Aims and Scope

The Oncology, Nuclear Medicine and Transplantology aims to be a premier platform for disseminating high-quality, peer-reviewed research that advances the science and clinical practice of oncology, nuclear medicine, and transplantation. The journal emphasizes interdisciplinary approaches that integrate molecular research, clinical practice, epidemiology, imaging, and health policy. It seeks to promote innovation, improve patient outcomes, and address regional and global challenges in cancer care, nuclear medicine applications, and organ transplantation, with a particular focus on Central Asia while maintaining an international perspective.

Scope

Oncology

The journal invites original research, reviews, case reports, and methodological studies in the following areas:

  1. Clinical Oncology

    • Diagnosis and management of solid tumors and hematologic malignancies.

    • Advances in surgery, radiotherapy, chemotherapy, targeted and immune-based therapies.

    • Supportive and palliative care approaches.

  2. Molecular and Translational Oncology

    • Cancer genetics, epigenetics, proteomics, and metabolomics.

    • Biomarker discovery and validation.

    • Experimental studies and preclinical cancer models.

  3. Cancer Epidemiology and Public Health

    • Population-based studies on cancer burden, risk factors, and outcomes.

    • Screening, prevention, and early detection programs.

    • Health disparities and access to oncology services.

  4. Innovations in Cancer Treatment

    • Clinical trials of novel therapeutics.

    • Personalized and precision oncology approaches.

    • Technological innovations in radiation oncology and surgical methods.

  5. Oncology Policy and Systems Research

    • Cancer control strategies, survivorship care, and palliative models.

    • Health economics and policy evaluation in oncology.

    • Regional and global cancer care initiatives.

Nuclear Medicine

The journal welcomes submissions in the following domains:

Nuclear Medicine Imaging and Diagnostics

  • PET, SPECT, CT, MRI, and hybrid imaging.

  • Novel radiopharmaceuticals and tracers.

  • AI, image analysis, and quantitative imaging methods.

Radionuclide Therapy and Theranostics

  • Targeted radionuclide therapy in oncology and non-oncological conditions.

  • Theranostic approaches uniting imaging and treatment.

  • Clinical trials and patient outcomes.

Molecular Imaging and Translational Research

  • Integration of imaging with precision medicine.

  • Biomarkers and radiogenomics in cancer care.

  • Experimental and translational research bridging lab to clinic.

Health Systems and Policy in Nuclear Medicine

  • Cost-effectiveness and health system performance.

  • Ethical, legal, and regulatory aspects of radiopharmaceutical use.

  • Regional capacity-building and collaborative strategies.

Transplantology

The journal welcomes submissions in the following domains:

Clinical and Surgical Advances in Transplantology

  • Organ preservation, donor-recipient matching, and immunosuppressive strategies.

  • Outcomes, complications, and long-term follow-up of transplant patients.

  • Surgical innovations across kidney, liver, heart, lung, and other organ transplants.

Imaging and Translational Research in Transplantology

  • Molecular imaging and biomarkers in transplantation.

  • Radiogenomics and precision medicine approaches.

  • Translational research connecting laboratory findings to clinical practice.

Health Systems and Policy in Transplantology

  • Cost-effectiveness and health system performance in transplantation.

  • Ethical, legal, and regulatory aspects of organ donation and transplant care.

  • Regional capacity-building and collaborative strategies.

 

Oncology, Nuclear Medicine and Transplantology is committed to advancing knowledge and fostering scholarly exchange in these fields. We welcome submissions from researchers worldwide and invite manuscripts to be submitted through our online system in the English language.